NEW YORK, New York — October 7, 2025 — Leads & Copy — Axsome Therapeutics, Inc. (NASDAQ: AXSM) will report its financial results for the third quarter of 2025 on Monday, November 3, 2025, before the opening of the U.S. financial markets. Axsome management will host a conference call at 8:00 a.m. Eastern Time to discuss the results and provide a business update.
To participate in the live conference call, dial (877) 405-1239 (toll-free domestic) or +1 (201) 389-0851 (international). A live webcast can be accessed on the “Webcasts & Presentations” page of the “Investors” section of the Company’s website. A replay will be available on the website for about 30 days.
Axsome Therapeutics is focused on treating central nervous system (CNS) conditions. Its portfolio includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness, and migraine, with late-stage programs addressing neurological and psychiatric conditions.
Contact:
Ashley Dong
Director, Investor Relations
(929) 687-1614
adong@axsome.com
Darren Opland
Senior Director, Corporate Communications
(929) 837-1065
dopland@axsome.com
Source: Axsome Therapeutics
